Visuospatial alpha and gamma oscillations scale with the severity of cognitive dysfunction in patients on the Alzheimer’s disease spectrum
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Visuospatial alpha and gamma oscillations scale with the severity of cognitive dysfunction in patients on the Alzheimer’s disease spectrum ; volume:13 ; number:1 ; day:17 ; month:8 ; year:2021 ; pages:1-12 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (17.8.2021), 1-12, 12.2021
- Creator
-
Wiesman, Alex I.
Murman, Daniel L.
May, Pamela E.
Schantell, Mikki
Wolfson, Sara L.
Johnson, Craig M.
Wilson, Tony W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00881-w
- URN
-
urn:nbn:de:101:1-2021110518581492456012
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wiesman, Alex I.
- Murman, Daniel L.
- May, Pamela E.
- Schantell, Mikki
- Wolfson, Sara L.
- Johnson, Craig M.
- Wilson, Tony W.
- SpringerLink (Online service)
Other Objects (12)
Early Cortical Changes in Gamma Oscillations in Alzheimer’s Disease
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Regional protein expression in human Alzheimer’s brain correlates with disease severity
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer’s Disease Severity
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
Alzheimer’s Disease
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Early Cortical Changes in Gamma Oscillations in Alzheimer’s Disease
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Regional protein expression in human Alzheimer’s brain correlates with disease severity
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer’s Disease Severity
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
Alzheimer’s Disease
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Early Cortical Changes in Gamma Oscillations in Alzheimer’s Disease
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Regional protein expression in human Alzheimer’s brain correlates with disease severity
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer’s Disease Severity
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
Alzheimer’s Disease
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set